Treating PIK3CA and EGFR overexpressing breast cancers with lithium citrate

被引：1

作者：

Brand, Toni M. ^{[1
]}

Wheeler, Deric L. ^{[1
]}

机构：

[1] Univ Wisconsin, Dept Human Oncol, Sch Med & Publ Hlth, Ctr Comprehens Canc, Madison, WI 53201 USA

来源：

CANCER BIOLOGY & THERAPY | 2011年 / 11卷 / 03期

关键词：

breast cancer; epidermal growth factor receptor (EGFR); lithium citrate; PIK3CA; receptor tyrosine kinase (RTK); METASTATIC COLORECTAL-CANCER; LUNG-CANCER; CETUXIMAB; MUTATIONS; KRAS; THERAPY;

D O I：

10.4161/cbt.11.3.14696

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

页码：368 / 370

页数：3

共 50 条

[31] Detection of PIK3CA mutations in circulating free DNA in patients with breast cancer
Ruth E. Board
Andrew M. Wardley
J. Michael Dixon
Anne C. Armstrong
Sacha Howell
Lorna Renshaw
Emma Donald
Alastair Greystoke
Malcolm Ranson
Andrew Hughes
Caroline Dive
Breast Cancer Research and Treatment, 2010, 120 : 461 - 467
[32] PIK3CA mutation profiling in Vietnamese patients with breast cancer
Vuong, Linh Dieu
Ta, To Van
Chu, Ha Hoang
Truong, Van-Long
Nguyen, Quang Ngoc
META GENE, 2020, 25
[33] Mutation distributions and clinical correlations of PIK3CA gene mutations in breast cancer
Dirican, Ebubekir
Akkiprik, Mustafa
Ozer, Ayse
TUMOR BIOLOGY, 2016, 37 (06) : 7033 - 7045
[34] Detection of PIK3CA mutations in circulating free DNA in patients with breast cancer
Board, Ruth E.
Wardley, Andrew M.
Dixon, J. Michael
Armstrong, Anne C.
Howell, Sacha
Renshaw, Lorna
Donald, Emma
Greystoke, Alastair
Ranson, Malcolm
Hughes, Andrew
Dive, Caroline
BREAST CANCER RESEARCH AND TREATMENT, 2010, 120 (02) : 461 - 467
[35] PIK3CA oncogenic mutations in neoadjuvant treatments for breast cancer
Corso, Giovanni
Veronesi, Paolo
Intra, Mattia
Sacchini, Virgilio
Galimberti, Viviana
BIOMARKERS IN MEDICINE, 2017, 11 (07) : 519 - 521
[36] PIK3CA somatic alterations in invasive breast cancers: different spectrum from Caucasians to Chinese detected by next generation sequencing
Jia, Minghan
Liao, Ning
Chen, Bo
Zhang, Guochun
Wang, Yulei
Li, Xuerui
Cao, Li
Mok, Hsiaopei
Ren, Chongyang
Li, Kai
Li, Cheukfai
Wen, Lingzhu
Lin, Jiali
Wei, Guangnan
Balch, Charles M.
BREAST CANCER, 2021, 28 (03) : 644 - 652
[37] EGFR gene copy number predicts response to anti-EGFR treatment in RAS wild type and RAS/BRAF/PIK3CA wild type metastatic colorectal cancer
Algars, Annika
Sundstrom, Jari
Lintunen, Minnamaija
Jokilehto, Terhi
Kytola, Soili
Kaare, Milja
Vainionpaa, Reetta
Orpana, Arto
Osterlund, Pia
Ristimaki, Ari
Carpen, Olli
Ristamaki, Raija
INTERNATIONAL JOURNAL OF CANCER, 2017, 140 (04) : 922 - 929
[38] Use of Liquid Biopsy to Detect PIK3CA Mutation in Metastatic Breast Cancer
Nakai, Maki
Yamada, Takeshi
Sekiya, Kenta
Sato, Ai
Hankyo, Meishi
Kuriyama, Sho
Takahashi, Goro
Kurita, Tomoko
Yanagihara, Keiko
Yoshida, Hiroshi
Ohashi, Ryuji
Takei, Hiroyuki
JOURNAL OF NIPPON MEDICAL SCHOOL, 2022, 89 (01) : 66 - 71
[39] Biomarkers of benefit from cetuximab-based therapy in metastatic colorectal cancer: interaction of EGFR ligand expression with RAS/RAF, PIK3CA genotypes
Pentheroudakis, George
Kotoula, Vassiliki
De Roock, Wendy
Kouvatseas, George
Papakostas, Pavlos
Makatsoris, Thomas
Papamichael, Demetris
Xanthakis, Ioannis
Sgouros, Joseph
Televantou, Despina
Kafiri, Georgia
Tsamandas, Athanassios C.
Razis, Evangelia
Galani, Eleni
Bafaloukos, Dimitrios
Efstratiou, Ioannis
Bompolaki, Iliada
Pectasides, Dimitrios
Pavlidis, Nicholas
Tejpar, Sabine
Fountzilas, George
BMC CANCER, 2013, 13
[40] The Effect and Treatment of PIK3CA Mutations in Breast Cancer: Current Understanding and Future Directions
Cho, Young-Bin
Park, Kyoung-Sik
MEDICINA-LITHUANIA, 2025, 61 (03):

← 1 2 3 4 5 →